View the presentations in this CME activity and complete the evaluation. Your certificate will be mailed to you upon satisfactory completion of these documents.
Epidemiology of HF & CKD in the General Population Ralph DeFronzo, MD
Guideline Directed Management of Heart Failure Biykem Bozkurt, MD, PhD
State of the Art Management of CKD Robert Toto, MD
The Intersection of CKD and HF Stephen Greene, MD
Panel Discussion - CKD and HF the Chicken and the Egg Case Presentation: Yehuda Handelsman, MD Panel: Ralph DeFronzo, MD • Stephen Greene, MD • Robert Toto, MD Biykem Bozkurt, MD, PhD
Moderator: Yehuda Handelsman, MD
Faculty
Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE
Medical Director & Principal Investigator
The Metabolic Institute of America
Chair & Program Director
World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) / Heart in Diabetes (HID)
Chair & Founder
International Committee for Insulin Resistance
Tarzana, California
Ralph A. DeFronzo, MD
Professor of Medicine Chief Diabetes Division University of Texas Health Science Center at San Antonio San Antonio, Texas
Biykem Bozkurt, MD, PhD, FHFSA, FACC, FAHA
Mary and Gordon Cain Chair and Professor of Medicine Associate Provost of Faculty Affairs Senior Associate Dean of Faculty Development Senior Associate Editor for Circulation AHA/ASA Journals
Editor-in-Chief of Journal of the American College of Cardiology
Baylor College of Medicine
Houston, Texas
Robert D. Toto, MD
Professor of Internal Medicine
Associate Dean Translational Science and Education
University of Texas Southwestern Medical Center
Dallas, Texas
Stephen Greene, MD, FACC
Assistant Professor, Division of Cardiology
Advanced Heart Failure & Transplantation
Duke University Medical Center
Duke Clinical Research Institute
Durham, North Carolina
Program Description
Recent cardiovascular outcome trials (CVOTs) have demonstrated prevention of ASCVD, HF & CKD in patients with and without diabetes. Of note sodium glucose cotransporter 2 (SGLT2) inhibitors and antiplatelet agents. The management of patients with HF & CKD is often limited by hyperkalemia which must be addressed when implementing therapy for the patient with multiple cardiorenal and metabolic conditions. Some therapies like SGLT2i have the potential to lower hyperkalemia however at times potassium binders are required.
In this CME satellite symposium, through a patient case, we will explore the complex challenges of treating patients with CKD, heart failure, and/or type 2 diabetes (T2D) who also have or are at risk for ASCVD. Specifically we'll address clinicians’ gaps in knowledge of the interconnections between CKD, ASCVD, heart failure, and T2D and the required comprehensive management of these conditions when presented in the same patient.
Learning Objectives
Upon completion of this CME symposium, participants should be able to:
Discuss the epidemiology of HF and CKD
Describe the evidence supporting treatment recommendations for HF and CKD
Compare and contrast the benefits and limitations of established and emerging treatments for both HF and CKD based on outcome trial evidence
Develop management strategies for patients with complicated disease, including those with CKD and heart failure
Target Audience
This educational initiative is designed for cardiologists, nephrologists, endocrinologists, internists, family physicians, and other healthcare professionals interested in the epidemiology, pathophysiology, prevention, and treatment of CKD and HF and prevention of morbidity and mortality.
CME Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PESI Inc., and Metabolic Endocrine Education Foundation (MEEF). PES Inc. is accredited by the ACCME to provide continuing medical education for physicians.
PESI, Inc, designated this live educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
